Osteoprotegerin treatment impairs remodeling and apparent material properties of callus tissue without influencing structural fracture strength.
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
The influence of osteoprotegerin (OPG) treatment on callus formation, callus tissue structural strength, apparent material properties, and histology of tibia fractures in rats was investigated after 3 weeks and 8 weeks of healing. OPG was given intravenously (10 mg/kg twice weekly) during the entire observation period, and control animals with fractures received vehicle only. When compared with control fractures after 3 weeks of healing, OPG treatment reduced the number of osteoclasts in the callus tissue (93%, P < 0.001) and hampered resorption of genuine cortical bone in the fracture line; OPG treatment did not influence callus dimensions, callus bone mineral content (BMC), fracture structural strength, or callus tissue apparent material properties. When compared with control fractures after 8 weeks of healing; OPG treatment reduced the number of osteoclasts in callus tissue (92%, P < 0.001), augmented callus dimensions (anteriorposterior diameter: 12%, P = 0.034, mediolateral diameter: 13%, P = 0.013), and increased callus BMC (50%, P = 0.007); OPG treatment hampered deposition of new woven bone at the fracture line of the genuine cortical bone (new woven bone present in all vehicle animals, but only in 13% of the OPG-treated animals (P < 0.001)); OPG treatment did not influence structural strength of the fractures, but decreased apparent material properties of the callus tissue (ultimate stress: 51%, P < 0.001; elastic modulus: 42%, P = 0.033). The experiment demonstrates that OPG treatment does not influence the early callus expansion and fracture strength. However, during the subsequent period of remodelling, OPG treatment impairs the normal remodeling and consolidation processes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“At wk 8, fracture calluses from OPGtreated rats were about 20% larger and had 30% greater BMC compared with vehicle controls.”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [363]
In the citing paper
“Consistent with this notion, the delayed callus remodeling associated with OPG treatment in rats resulted in larger calluses that were able to withstand the same amount of biomechanical force as did the calluses of untreated rats (363).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [363]
In the citing paper
“Histological assessment of fracture calluses at wk 3 and 8 showed greater than 90% reductions in osteoclast numbers in OPG-treated rats compared with time-matched vehicle controls.”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [363]
In the citing paper
“At wk 3, there were no reported differences in callus dimensions, BMC, or biomechanical strength of the callus between OPGand vehicle-treated controls.”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [363]
Citations
Cites
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.
Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130 · cited 2×
“These studies include osteoporosis [4], erosive arthritis [6], humoral hypercalcemia of malignancy [7, 8], experimental bone metastasis [9], and wear debris–induced osteolysis [10, 11].”
BackgroundBone Resorption by Osteoclasts
Teitelbaum, S. L. (2000) · Science · doi:10.1126/science.289.5484.1504 · Cited by 3,962 · cited 1×
“The key factor in the development and activation of osteoclasts is the receptor activator of NFjB ligand (RANKL), which binds to its receptor (RANK) on osteoclast precursor cells and stimulates osteoclastogenesis and bone resorption [1–3].”
BackgroundKong, Y.-Y., Feige, U., Sarosi, I., Bolon, B., Tafuri, A., Morony, S., Capparelli, C., Li, J., Elliott, R., McCabe, S., et al. (1999) · Nature · doi:10.1038/46303 · Cited by 1,856 · cited 1×
“These studies include osteoporosis [4], erosive arthritis [6], humoral hypercalcemia of malignancy [7, 8], experimental bone metastasis [9], and wear debris–induced osteolysis [10, 11].”
BackgroundBasic orthopaedic biomechanics
Mow, V. C., & Hayes, W. C. (1991) · Medical Entomology and Zoology · Cited by 655
Role of receptor activator of nuclear factor-κB ligand and osteoprotegerin in bone cell biology
Hofbauer, L. C., & Heufelder, A. E. (2001) · Journal of Molecular Medicine · doi:10.1007/s001090100226 · Cited by 586 · cited 1×
“The key factor in the development and activation of osteoclasts is the receptor activator of NFjB ligand (RANKL), which binds to its receptor (RANK) on osteoclast precursor cells and stimulates osteoclastogenesis and bone resorption [1–3].”
BackgroundKon, T., Cho, T.-J., Aizawa, T., Yamazaki, M., Nooh, N., Graves, D., Gerstenfeld, L. C., & Einhorn, T. A. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.6.1004 · Cited by 552 · cited 1×
“It has been demonstrated that cellular expression of OPG and RANKL in murine callus tissue is tightly coupled during fracture healing and is involved in the regulation of both endochondral resorption and remodeling [13].”
BackgroundThe effect of a single dose of osteoprotegerin in postmenopausal women.
Bekker, P. J., Holloway, D., Nakanishi, A., Arrighi, M., Leese, P. T., & Dunstan, C. R. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.2.348 · Cited by 484 · cited 1×
“Furthermore, a clinical investigation with OPG in postmenopausal women has demonstrated that bone turnover could be reduced by only one single injection ofOPG [12].”
BackgroundZhang, J., Dai, J., Qi, Y., Lin, D.-L., Smith, P., Strayhorn, C., Mizokami, A., Fu, Z., Westman, J., & Keller, E. T. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11685 · Cited by 452 · cited 1×
“These studies include osteoporosis [4], erosive arthritis [6], humoral hypercalcemia of malignancy [7, 8], experimental bone metastasis [9], and wear debris–induced osteolysis [10, 11].”
BackgroundAndreassen, T. T., Ejersted, C., & Oxlund, H. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.6.960 · Cited by 346 · cited 3×
“Fracture healing was examined in vivo using the rat tibia fracture model as we have described previously in detail [14, 15].”
BackgroundMethodSelf-citationMorony, S., Capparelli, C., Sarosi, I., Lacey, D. L., Dunstan, C. R., & Kostenuik, P. J. (2001) · PubMed · Cited by 318
Research works printed but not linked: 2
- S Morony, 2001, Cancer Res, 61, 4432
- C Capparelli, 2000, Cancer Res, 60, 783
Cited by
Bone remodeling during fracture repair: The cellular picture
Schindeler, A., McDonald, M. M., Bokko, P., & Little, D. G. (2008) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2008.07.004 · Cited by 961
Kearns, A. E., Khosla, S., & Kostenuik, P. J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0014 · Cited by 824
Cellular biology of fracture healing
Bahney, C. S., Zondervan, R. L., Allison, P., Theologis, A., Ashley, J. W., Ahn, J., Miclau, T., Marcucio, R. S., & Hankenson, K. D. (2019) · Journal of Orthopaedic Research · doi:10.1002/jor.24170 · Cited by 577
Osteal macrophages promote in vivo intramembranous bone healing in a mouse tibial injury model
Alexander, K. A., Chang, M. K., Maylin, E. R., Kohler, T., Müller, R., Wu, A. C., Van Rooijen, N., Sweet, M. J., Hume, D. A., Raggatt, L. J., et al. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.354 · Cited by 485
“Other studies in animal models of fracture have inhibited osteoclast number and function either via OPG,((52)) denosumab,((53)) or bisphosphonate treatment((53,54)) and concluded that osteoclasts were not required for normal callus formation but were important during hard callus remodeling.”
BackgroundKostenuik, P. J., Nguyen, H. Q., McCabe, J., Warmington, K. S., Kurahara, C., Sun, N., Chen, C., Li, L., Cattley, R. C., Van, G., et al. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.081112 · Cited by 443
“callus formation and positive effects on callus strength despite delays in callus remodeling.((46,47)) In summary, OPG and denosumab inhibit osteoclasto-”
BackgroundRaggatt, L. J., Wullschleger, M. E., Alexander, K. A., Wu, A. C. K., Millard, S. M., Kaur, S., Maugham, M. L., Gregory, L. S., Steck, R., & Pettit, A. R. (2014) · The American Journal of Pathology · doi:10.1016/j.ajpath.2014.08.017 · Cited by 283
Gerstenfeld, L. C., Sacks, D. J., Pelis, M., Mason, Z. D., Graves, D. T., Barrero, M., Ominsky, M. S., Kostenuik, P. J., Morgan, E. F., & Einhorn, T. A. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.081113 · Cited by 218
“In previous studies, two receptor RANKL inhibitors (OPG-Fc and RANK-Fc) were tested in rat and mouse models of fracture repair, respectively.((5,6)) Both of these studies have shown no effect on fracture union, and no significant effects were observed on fracture strength with high-doses of OPG-Fc at 3 and 8 wk after…”
BackgroundMethodResultQiao, W., Xie, H., Fang, J., Shen, J., Li, W., Shen, D., Wu, J., Wu, S., Liu, X., Zheng, Y., et al. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.121038 · Cited by 141
“In contrast, the inhibition of the osteoclast function via OPG [72], Denosumab [73], and Zoledronate [74] treatment results in compromised bone healing because osteoclast deficiency leads to a disorganized matrix and a reduced”
BackgroundInfluentialAdami, S., Libanati, C. R., Boonen, S., Cummings, S. R., Ho, P., Wang, A., Siris, E. S., Lane, J. M., Adachi, J. D., Bhandari, M., et al. (2012) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.k.00774 · Cited by 132
Dunn, M. D., Park, C. H., Kostenuik, P. J., Kapila, S., & Giannobile, W. V. (2007) · Bone · doi:10.1016/j.bone.2007.04.194 · Cited by 121
“It has also been demonstrated that excess OPG actually impairs bone remodeling in a situation such as callus repair following fracture indicating that the ideal ratio of OPG to RANKL is dependent on the mechanical model being employed [12].”
BackgroundBaker, C. E., Moore‐Lotridge, S. N., Hysong, A. A., Posey, S. L., Robinette, J. P., Blum, D. M., Benvenuti, M. A., Cole, H., Egawa, S., Okawa, A., et al. (2018) · Clinical Reviews in Bone and Mineral Metabolism · doi:10.1007/s12018-018-9256-x · Cited by 113
Colnot, C., Huang, S., & Helms, J. A. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.09.079 · Cited by 95
Role of RANKL in bone diseases
Anandarajah, A. (2009) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2008.10.007 · Cited by 84
Gorter, E. A., Reinders, C. R., Krijnen, P., Appelman‐Dijkstra, N. M., & Schipper, I. B. (2021) · Bone Reports · doi:10.1016/j.bonr.2021.101117 · Cited by 89
Schett, G. A., Stolina, M., Dwyer, D., Zack, D. J., Uderhardt, S., Krönke, G., Kostenuik, P. J., & Feige, U. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24767 · Cited by 79
Overview of Skeletal Repair (Fracture Healing and Its Assessment)
Morgan, E. F., Giacomo, A. F. D., & Gerstenfeld, L. C. (2014) · Methods in molecular biology · doi:10.1007/978-1-62703-989-5_2 · Cited by 80
Impact of osteoporosis and osteoporosis medications on fracture healing: a narrative review
Chandran, M., Åkesson, K., Javaid, M. K., Harvey, N. C., Blank, R. D., Brandi, M. L., Chevalley, T., Cinelli, P., Cooper, C. C., Lems, W. F., et al. (2024) · Osteoporosis International · doi:10.1007/s00198-024-07059-8 · Cited by 79
“However limited data in non-osteoporotic animal models show that though treatment with osteoprotegerin (OPG)—a natural RANKL inhibitor, did not influence callus formation or mechanical strength in female rats, it impaired normal remodelling [22].”
BackgroundLuo, Y., Zhang, H., Wang, Z., Jiao, J., Wang, Y., Jiang, W., Yu, T., Liu, H., Guan, L., Li, M., et al. (2025) · Regenerative Biomaterials · doi:10.1093/rb/rbaf068 · Cited by 77
“Through the osteogenic differentiation, proliferation and mineralization of these progenitor cells, the soft callus is converted into a hard callus, stabilizing the new bone tissue [273, 274].”
Wallimann, A., Magrath, W. J., Pugliese, B. R., Stocker, N., Westermann, P., Heider, A., Gehweiler, D., Zeiter, S., Claesson, M. J., Richards, R. G., et al. (2021) · Mediators of Inflammation · doi:10.1155/2021/8817421 · Cited by 59
“Inter-estingly, OPG treatment in rats impaired callus remodeling by reducing osteoclast numbers, although it did not in fl uence early callus expansion [58].”
Yahara, Y., Ma, X., Gracia, L., & Alman, B. A. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.622035 · Cited by 51
“E-cadherin is a cell surface glycoprotein responsible for cell-cell adhesion and IL-4-driven macrophage fusion (Mbalaviele et al., 1995; Van den Bossche et al., 2009).”
BackgroundTakeyama, K., Chatani, M., Takano, Y., & Kudō, A. (2014) · Developmental Biology · doi:10.1016/j.ydbio.2014.08.007 · Cited by 45
Emerging treatments for postmenopausal osteoporosis – focus on denosumab
Geusens, P. (2009) · Clinical Interventions in Aging · doi:10.2147/cia.s3333 · Cited by 44
“In studies of the effect of RANKL inhibition on fracture repair, high doses of OPG given to rats at the time of fracture did not influence the formation of a normal fracture callus, but delayed callus remodeling.(42) In an animal study of transverse femur fracture healing, alendronate and denosumab delayed the removal…”
Anti-RANKL treatment improves screw fixation in cancellous bone in rats
Bernhardsson, M., Sandberg, O., & Aspenberg, P. (2015) · Injury · doi:10.1016/j.injury.2015.02.011 · Cited by 40
“In studies of diaphyseal fracture healing in rat or mouse, inhibited RANKL signalling increased the strength and stiffness of fractured bones and prolonged the remodelling of callus during later phases of healing [16–18].”
BackgroundRANKL inhibition for the management of patients with benign metabolic bone disorders
Anastasilakis, A. D., Toulis, K. A., Pοlyzos, S. A., & Terpos, E. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780903048929 · Cited by 39
“It seems that RANKL plays a role in callus remodeling but not callus formation [51].”
BackgroundKarsdal, M. A., Qvist, P., Christiansen, C., & Tank, L. S. B. (2006) · Drugs · doi:10.2165/00003495-200666150-00002 · Cited by 40
McDonald, M. M., Morse, A., Mikulec, K., Peacock, L., Baldock, P. A. J., Kostenuik, P. J., & Little, D. G. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1889 · Cited by 33
“Further, based on previously published work,((3,5,6,27,39,41)) although the larger calluses produced by 6 weeks with ZA, CLOD, and OPG would be stronger in resistance to load, the material properties of the largely unremodeled woven bone callus is likely inferior to remodeled bone in the saline‐treated callus.”
BackgroundMethodPlatelet‐derived growth factor stimulates osteoprotegerin production in osteoblastic cells
McCarthy, H. S., Williams, J. H. H., Davie, M. W. J., & Marshall, M. J. E. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21600 · Cited by 32
The Life of a Fracture: Biologic Progression, Healing Gone Awry, and Evaluation of Union
Hellwinkel, J. E., Miclau, T., Provencher, M. T., Bahney, C. S., & Working, Z. M. (2020) · JBJS Reviews · doi:10.2106/jbjs.rvw.19.00221 · Cited by 30
Beyond resorption: osteoclasts as drivers of bone formation
Xiang, Q., Li, L., Ji, W., Gawlitta, D., Walboomers, X. F., & van den Beucken, J. J. J. P. (2024) · Cell Regeneration · doi:10.1186/s13619-024-00205-x · Cited by 33
“This indicates that the transformation of the sizable woven bone callus into a compact lamellar structure heavily relies on OC activity (Ulrich-Vinther and Andreassen 2005).”
BackgroundHisting, T., Stenger, D., Kuntz, S., Scheuer, C., Tami, A., Garcia, P., Holstein, J. H., Klein, M., Pohlemann, T., & Menger, M. D. (2011) · Journal of Surgical Research · doi:10.1016/j.jss.2011.03.052 · Cited by 25
“Of interest, Ulrich-Vinther and Andreassen [25] reported that OPG treatment after tibia fracture in normal rats increases callus dimensions and, thus, impairs the normal remodeling process.”
BackgroundImpaired Fracture Healing Caused by Deficiency of the Immunoreceptor Adaptor Protein DAP12
Kamimura, M., Mori, Y., Sugahara–Tobinai, A., Takai, T., & Itoi, E. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128210 · Cited by 31
“However, in contrast to our results, recent studies examining fracture repair in osteoclast-deficient or osteoclast-inhibited animals using incisors [14], anti-RANK ligand antibody [31], recombinant osteoprotegerin [17], or zoledronic acid [15] showed no delay in cartilaginous callus resorption or woven bone formation.”
ResultThe role and efficacy of denosumab in the treatment of osteoporosis: an update
Charopoulos, I., Orme, S. M., & Giannoudis, P. V. (2011) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2010.516249 · Cited by 29
“The results have shown no effect on fracture union and no significant effect on fracture strength with high doses of RANKL inhibitors at 3 and 8 weeks after fracture [56,57].”
BackgroundUlrich‐Vinther, M., Schwarz, E. M., Pedersen, F. S., Søballé, K., & Andreassen, T. T. (2005) · Bone · doi:10.1016/j.bone.2005.07.021 · Cited by 27
Self-citationOverview of Skeletal Repair (Fracture Healing and Its Assessment)
Morgan, E. F., Giacomo, A. F. D., & Gerstenfeld, L. C. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-1028-2_2 · Cited by 17
The effect of osteoprotegerin on implant osseointegration in ovariectomized rats
Liu, Y., Hu, J., Liu, B., Jiang, X., & Li, Y. (2017) · Archives of Medical Science · doi:10.5114/aoms.2017.65468 · Cited by 18
“Previous animal studies have indicated the bone protective role of OPG, but this bone protective role might not be induced by promoting bone formation to a normal level or improving bone microarchitecture, but inhibiting bone resorption and increasing percent mineral composition [22, 27, 28].”
Denosumab in postmenopausal osteoporosis: what the clinician needs to know
Lewiecki, E. M. (2009) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x09343221 · Cited by 13
“In rats with fractures, administration of OPG does not influence early callus formation or fracture strength, although it does impair callus remodeling and consolidation [Ulrich-Vinther and Andreassen, 2005].”
BackgroundKakar, S., Little, D. G., & Einhorn, T. A. (2009) · Journal of Orthopaedic Trauma · doi:10.1097/bot.0b013e3181ac64a0 · Cited by 12
Macrophages and osteoclasts: similarity and divergence between bone phagocytes
Halper, J., Dolfi, B., Ivanov, S., Madel, M., & Blin‐Wakkach, C. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1683872 · Cited by 14
Nurdiana, N., Mariati, N., Noorhamdani, N., Setiawan, B., Budhiparama, N. C., & Noor, Z. (2018) · Clinical Nutrition Experimental · doi:10.1016/j.yclnex.2018.01.002 · Cited by 9
Orthobiologics in the Augmentation of Osteoporotic Fractures
Watson, J. T., & Nicolaou, D. (2014) · Current Osteoporosis Reports · doi:10.1007/s11914-014-0249-5 · Cited by 9
The role of rank-ligand inhibition in the treatment of postmenopausal osteoporosis
VARENNA, M., & Gatti, D. (2011) · Reumatismo · doi:10.4081/reumatismo.2010.163 · Cited by 7
“Effetto sulla riparazione delle fratture Gli studi eseguiti su animali da esperimento con OPG ad elevato dosaggio non hanno evidenziato eventuali effetti negativi sulla formazione del callo osseo in seguito a fratture (41).”
BackgroundPharmacological mechanisms of therapeutics
Tsourdi, E. A., Ominsky, M. S., Rachner, T. D., Hofbauer, L. C., & Kostenuik, P. J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814841-9.00073-7 · Cited by 4
Biomechanics of Fracture Healing
Morgan, E. F., Hussein, A. I., & Einhorn, T. A. (2018) · Wiley eBooks · doi:10.1002/9781119266594.ch14 · Cited by 3
Chapter 12. Biomechanics of Fracture Healing
Morgan, E. F., & Einhorn, T. A. (2008) · Primer on the metabolic bone diseases and disorders of mineral metabolism · doi:10.1002/9780470623992.ch12 · Cited by 3
Biomechanics of Fracture Healing
Morgan, E. F., & Einhorn, T. A. (2013) · Wiley eBooks · doi:10.1002/9781118453926.ch12 · Cited by 3
Stem cells and regenerative medicine for musculoskeletal tissue
Payne, E. R., Ji, J., Xiao, D., & Shen, J. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823893-6.00008-5
Metadata
- Authors
- Ulrich-Vinther, M., & Andreassen, T. T.
- Affiliations
- Aarhus University (DK)
- Venue
- Calcified Tissue International
- Published
- 2005-04
- Volume
- 76
- Issue
- 4
- Pages
- 280-286
- ISSN
- 0171-967X (ISSN-L)
- 1432-0827
- OpenAlex
- W2017820958
- Cited by
- 46
- References
- 36
- Citations by year
- 2025: 2 · 2024: 2 · 2022: 1 · 2021: 4 · 2020: 2 · 2019: 1 · 2018: 4 · 2017: 1 · 2015: 2 · 2014: 4 · 2013: 2 · 2012: 1
- FWCI
- 1.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Calcified Tissue International (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone fractures and treatments
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Keywords
- osteoprotegerin, fracture healing, callus, bone remodeling, osteoclasts, cortical bone resorption, fracture strength, elastic modulus, ultimate stress, bone mineral content, tibial fractures, RANKL inhibition
- MeSH terms
- Animals, Bony Callus, Female, Glycoproteins, Injections, Intravenous, Osteoclasts, Stress, Mechanical, Tibia, Absorptiometry, Photon, Bone Density, Weight-Bearing, Bone Remodeling, Fracture Healing, Rats, Wistar, Receptors, Tumor Necrosis Factor, Receptors, Cytoplasmic and Nuclear, Compressive Strength, Rats, Osteoprotegerin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.